本页面由Tiger Trade Technology Pte. Ltd.提供服务

Kura Oncology, Inc

8.58
-0.1500-1.72%
盘后8.760.1800+2.10%19:53 EDT
成交量:80.59万
成交额:695.90万
市值:7.58亿
市盈率:-2.70
高:8.83
开:8.80
低:8.56
收:8.73
52周最高:12.49
52周最低:5.41
股本:8,832.98万
流通股本:6,398.56万
量比:0.57
换手率:1.26%
股息:- -
股息率:- -
每股收益(TTM):-3.1784
每股收益(LYR):-3.1784
净资产收益率:-94.82%
总资产收益率:-25.33%
市净率:4.35
市盈率(LYR):-2.70

数据加载中...

2026/03/05

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/03/05

重要事件披露

Form 8-K - Current report
2026/01/29

重要事件披露

Form 8-K - Current report
2026/01/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/12

重要事件披露

Form 8-K - Current report
2025/12/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/02

重要事件披露

Form 8-K - Current report
2025/11/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/13

重要事件披露

Form 8-K - Current report
2025/11/04

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans